Kristen Landon - 17 Jan 2025 Form 4 Insider Report for 60 DEGREES PHARMACEUTICALS, INC. (SXTP)

Role
Chief Operating Officer
Signature
/s/ Kristen Landon
Issuer symbol
SXTP
Transactions as of
17 Jan 2025
Net transactions value
$0
Form type
4
Filing time
14 Aug 2025, 21:23:53 UTC
Previous filing
14 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Landon Kristen Chief Operating Officer C/O 60 DEGREES PHARMACEUTICALS, INC., 1025 CONNECTICUT AVENUE NW SUITE 1000, WASHINGTON /s/ Kristen Landon 14 Aug 2025 0002053910

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SXTP Common Stock Award $0 +4,540 $0.000000 4,540 17 Jan 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed late due to an inadvertent administrative error.
F2 The number of shares has been adjusted to reflect the 1-for-5 reverse stock split effected by the Issuer on February 24, 2025.